Cosmos Health Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cosmos Health Inc. (Nasdaq: COSM) on October 6, 2025, reporting events that occurred on September 30, 2025. The company is incorporated in Nevada with principal executive offices in Thessaloniki, Greece.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Theodoros C. Karkantzos to the Board of Directors and the Nominating and Corporate Governance Committee, effective September 30, 2025. Mr. Karkantzos was elected at the annual general meeting of stockholders held on the same date.
Management Commentary, Risks, and Compensation
- Compensation: Mr. Karkantzos will receive an annual cash fee of $10,000 for Board participation and a $5,000 fee for his role on the Nominating & Corporate Governance Committee. He will also be granted shares under the Company's 2025 Omnibus Incentive Plan.
- Background: Mr. Karkantzos brings over 15 years of experience in investment and business development, including co-founding Blue Dot Digital Agency and holding advanced degrees from the University of Cambridge and the University of Warwick.
- Prior Relationship: From July 1, 2024, to August 28, 2025, Mr. Karkantzos provided consulting services to the Company through C Capital Media Ltd. without receiving cash or equity compensation for those specific services.
- Risks and Contingencies: The filing states there are no other transactions or proposed transactions in which Mr. Karkantzos or his immediate family has a material interest, except as disclosed.
Investor Verification Checklist
- Verify the terms of the equity grant under the 2025 Omnibus Incentive Plan referenced in the filing.
- Review the Definitive Proxy Statement (Form 14A) filed on August 22, 2025, for details on the Omnibus Incentive Plan.
- Confirm the voting results of the September 30, 2025, annual general meeting regarding Mr. Karkantzos's election.
- Monitor future filings for any financial updates, as this 8-K contains no financial metrics.